According to new survey, global Pediatric Orphan Drugs market is projected to reach US$ 102180 million in 2029, increasing from US$ 51490 million in 2022, with the CAGR of 10.5% during the period of 2023 to 2029.

Pediatric Orphan Drugs Market

Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Orphan Drugs market research.

According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022, followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pediatric Orphan Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Pediatric Orphan Drugs Market Report

Report Metric	Details
Report Name	Pediatric Orphan Drugs Market
Accounted market size in 2022	US$ 51490 million
Forecasted market size in 2029	US$ 102180 million
CAGR	10.5%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Oncology Drugs Gastrointestinal Drugs Neurology Drugs Cardio-vascular Drugs Others
Segment by Application	Hospital Pharmacies Retail pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recordati SpA, Novartis, Celgene, Abbvie, Orpharma, Amgen, Amryt Pharma Plc., Johnson & Johnson, GSK, Bristol-Myers Squibb Company, Roche Holding, Pfizer, Sanofi, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Pediatric Orphan Drugs Market growing?

Ans: The Pediatric Orphan Drugs Market witnessing a CAGR of 10.5% during the forecast period 2023-2029.

What is the Pediatric Orphan Drugs Market size in 2029?

Ans: The Pediatric Orphan Drugs Market size in 2029 will be US$ 102180 million.

Who are the main players in the Pediatric Orphan Drugs Market report?

Ans: The main players in the Pediatric Orphan Drugs Market are Recordati SpA, Novartis, Celgene, Abbvie, Orpharma, Amgen, Amryt Pharma Plc., Johnson & Johnson, GSK, Bristol-Myers Squibb Company, Roche Holding, Pfizer, Sanofi, Takeda

What are the Application segmentation covered in the Pediatric Orphan Drugs Market report?

Ans: The Applications covered in the Pediatric Orphan Drugs Market report are Hospital Pharmacies, Retail pharmacies, Others

What are the Type segmentation covered in the Pediatric Orphan Drugs Market report?

Ans: The Types covered in the Pediatric Orphan Drugs Market report are Oncology Drugs, Gastrointestinal Drugs, Neurology Drugs, Cardio-vascular Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Oncology Drugs

1.2.3 Gastrointestinal Drugs

1.2.4 Neurology Drugs

1.2.5 Cardio-vascular Drugs

1.2.6 Others

1.3 Market by Application

1.3.1 Global Pediatric Orphan Drugs Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacies

1.3.3 Retail pharmacies

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pediatric Orphan Drugs Market Perspective (2018-2029)

2.2 Pediatric Orphan Drugs Growth Trends by Region

2.2.1 Global Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2018-2023)

2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029)

2.3 Pediatric Orphan Drugs Market Dynamics

2.3.1 Pediatric Orphan Drugs Industry Trends

2.3.2 Pediatric Orphan Drugs Market Drivers

2.3.3 Pediatric Orphan Drugs Market Challenges

2.3.4 Pediatric Orphan Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pediatric Orphan Drugs Players by Revenue

3.1.1 Global Top Pediatric Orphan Drugs Players by Revenue (2018-2023)

3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2018-2023)

3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pediatric Orphan Drugs Revenue

3.4 Global Pediatric Orphan Drugs Market Concentration Ratio

3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2022

3.5 Pediatric Orphan Drugs Key Players Head office and Area Served

3.6 Key Players Pediatric Orphan Drugs Product Solution and Service

3.7 Date of Enter into Pediatric Orphan Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Orphan Drugs Breakdown Data by Type

4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2018-2023)

4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029)

5 Pediatric Orphan Drugs Breakdown Data by Application

5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2018-2023)

5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Pediatric Orphan Drugs Market Size (2018-2029)

6.2 North America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pediatric Orphan Drugs Market Size by Country (2018-2023)

6.4 North America Pediatric Orphan Drugs Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pediatric Orphan Drugs Market Size (2018-2029)

7.2 Europe Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pediatric Orphan Drugs Market Size by Country (2018-2023)

7.4 Europe Pediatric Orphan Drugs Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pediatric Orphan Drugs Market Size (2018-2029)

8.2 Asia-Pacific Pediatric Orphan Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023)

8.4 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pediatric Orphan Drugs Market Size (2018-2029)

9.2 Latin America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023)

9.4 Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pediatric Orphan Drugs Market Size (2018-2029)

10.2 Middle East & Africa Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023)

10.4 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Recordati SpA

11.1.1 Recordati SpA Company Detail

11.1.2 Recordati SpA Business Overview

11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction

11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.1.5 Recordati SpA Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Pediatric Orphan Drugs Introduction

11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 Celgene

11.3.1 Celgene Company Detail

11.3.2 Celgene Business Overview

11.3.3 Celgene Pediatric Orphan Drugs Introduction

11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.3.5 Celgene Recent Development

11.4 Abbvie

11.4.1 Abbvie Company Detail

11.4.2 Abbvie Business Overview

11.4.3 Abbvie Pediatric Orphan Drugs Introduction

11.4.4 Abbvie Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.4.5 Abbvie Recent Development

11.5 Orpharma

11.5.1 Orpharma Company Detail

11.5.2 Orpharma Business Overview

11.5.3 Orpharma Pediatric Orphan Drugs Introduction

11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.5.5 Orpharma Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Pediatric Orphan Drugs Introduction

11.6.4 Amgen Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.6.5 Amgen Recent Development

11.7 Amryt Pharma Plc.

11.7.1 Amryt Pharma Plc. Company Detail

11.7.2 Amryt Pharma Plc. Business Overview

11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction

11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.7.5 Amryt Pharma Plc. Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Detail

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction

11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.8.5 Johnson & Johnson Recent Development

11.9 GSK

11.9.1 GSK Company Detail

11.9.2 GSK Business Overview

11.9.3 GSK Pediatric Orphan Drugs Introduction

11.9.4 GSK Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.9.5 GSK Recent Development

11.10 Bristol-Myers Squibb Company

11.10.1 Bristol-Myers Squibb Company Company Detail

11.10.2 Bristol-Myers Squibb Company Business Overview

11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction

11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.10.5 Bristol-Myers Squibb Company Recent Development

11.11 Roche Holding

11.11.1 Roche Holding Company Detail

11.11.2 Roche Holding Business Overview

11.11.3 Roche Holding Pediatric Orphan Drugs Introduction

11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.11.5 Roche Holding Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Detail

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Pediatric Orphan Drugs Introduction

11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.12.5 Pfizer Recent Development

11.13 Sanofi

11.13.1 Sanofi Company Detail

11.13.2 Sanofi Business Overview

11.13.3 Sanofi Pediatric Orphan Drugs Introduction

11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.13.5 Sanofi Recent Development

11.14 Takeda

11.14.1 Takeda Company Detail

11.14.2 Takeda Business Overview

11.14.3 Takeda Pediatric Orphan Drugs Introduction

11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023)

11.14.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol Myers Squibb Company

List of Tables

Table 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Oncology Drugs

Table 3. Key Players of Gastrointestinal Drugs

Table 4. Key Players of Neurology Drugs

Table 5. Key Players of Cardio-vascular Drugs

Table 6. Key Players of Others

Table 7. Global Pediatric Orphan Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Pediatric Orphan Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 9. Global Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 10. Global Pediatric Orphan Drugs Market Share by Region (2018-2023)

Table 11. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 12. Global Pediatric Orphan Drugs Market Share by Region (2024-2029)

Table 13. Pediatric Orphan Drugs Market Trends

Table 14. Pediatric Orphan Drugs Market Drivers

Table 15. Pediatric Orphan Drugs Market Challenges

Table 16. Pediatric Orphan Drugs Market Restraints

Table 17. Global Pediatric Orphan Drugs Revenue by Players (2018-2023) & (US$ Million)

Table 18. Global Pediatric Orphan Drugs Market Share by Players (2018-2023)

Table 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)

Table 20. Ranking of Global Top Pediatric Orphan Drugs Companies by Revenue (US$ Million) in 2022

Table 21. Global 5 Largest Players Market Share by Pediatric Orphan Drugs Revenue (CR5 and HHI) & (2018-2023)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Pediatric Orphan Drugs Product Solution and Service

Table 24. Date of Enter into Pediatric Orphan Drugs Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 27. Global Pediatric Orphan Drugs Revenue Market Share by Type (2018-2023)

Table 28. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 29. Global Pediatric Orphan Drugs Revenue Market Share by Type (2024-2029)

Table 30. Global Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 31. Global Pediatric Orphan Drugs Revenue Market Share by Application (2018-2023)

Table 32. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 33. Global Pediatric Orphan Drugs Revenue Market Share by Application (2024-2029)

Table 34. North America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 35. North America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 36. North America Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 37. Europe Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. Europe Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 39. Europe Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 40. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 41. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 42. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029) & (US$ Million)

Table 43. Latin America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 45. Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 46. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 47. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 48. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 49. Recordati SpA Company Detail

Table 50. Recordati SpA Business Overview

Table 51. Recordati SpA Pediatric Orphan Drugs Product

Table 52. Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 53. Recordati SpA Recent Development

Table 54. Novartis Company Detail

Table 55. Novartis Business Overview

Table 56. Novartis Pediatric Orphan Drugs Product

Table 57. Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Celgene Company Detail

Table 60. Celgene Business Overview

Table 61. Celgene Pediatric Orphan Drugs Product

Table 62. Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 63. Celgene Recent Development

Table 64. Abbvie Company Detail

Table 65. Abbvie Business Overview

Table 66. Abbvie Pediatric Orphan Drugs Product

Table 67. Abbvie Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 68. Abbvie Recent Development

Table 69. Orpharma Company Detail

Table 70. Orpharma Business Overview

Table 71. Orpharma Pediatric Orphan Drugs Product

Table 72. Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 73. Orpharma Recent Development

Table 74. Amgen Company Detail

Table 75. Amgen Business Overview

Table 76. Amgen Pediatric Orphan Drugs Product

Table 77. Amgen Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 78. Amgen Recent Development

Table 79. Amryt Pharma Plc. Company Detail

Table 80. Amryt Pharma Plc. Business Overview

Table 81. Amryt Pharma Plc. Pediatric Orphan Drugs Product

Table 82. Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 83. Amryt Pharma Plc. Recent Development

Table 84. Johnson & Johnson Company Detail

Table 85. Johnson & Johnson Business Overview

Table 86. Johnson & Johnson Pediatric Orphan Drugs Product

Table 87. Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 88. Johnson & Johnson Recent Development

Table 89. GSK Company Detail

Table 90. GSK Business Overview

Table 91. GSK Pediatric Orphan Drugs Product

Table 92. GSK Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 93. GSK Recent Development

Table 94. Bristol-Myers Squibb Company Company Detail

Table 95. Bristol-Myers Squibb Company Business Overview

Table 96. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product

Table 97. Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 98. Bristol-Myers Squibb Company Recent Development

Table 99. Roche Holding Company Detail

Table 100. Roche Holding Business Overview

Table 101. Roche Holding Pediatric Orphan Drugs Product

Table 102. Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 103. Roche Holding Recent Development

Table 104. Pfizer Company Detail

Table 105. Pfizer Business Overview

Table 106. Pfizer Pediatric Orphan Drugs Product

Table 107. Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 108. Pfizer Recent Development

Table 109. Sanofi Company Detail

Table 110. Sanofi Business Overview

Table 111. Sanofi Pediatric Orphan Drugs Product

Table 112. Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 113. Sanofi Recent Development

Table 114. Takeda Company Detail

Table 115. Takeda Business Overview

Table 116. Takeda Pediatric Orphan Drugs Product

Table 117. Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)

Table 118. Takeda Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pediatric Orphan Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Pediatric Orphan Drugs Market Share by Type: 2022 VS 2029

Figure 3. Oncology Drugs Features

Figure 4. Gastrointestinal Drugs Features

Figure 5. Neurology Drugs Features

Figure 6. Cardio-vascular Drugs Features

Figure 7. Others Features

Figure 8. Global Pediatric Orphan Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 9. Global Pediatric Orphan Drugs Market Share by Application: 2022 VS 2029

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail pharmacies Case Studies

Figure 12. Others Case Studies

Figure 13. Pediatric Orphan Drugs Report Years Considered

Figure 14. Global Pediatric Orphan Drugs Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 15. Global Pediatric Orphan Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 16. Global Pediatric Orphan Drugs Market Share by Region: 2022 VS 2029

Figure 17. Global Pediatric Orphan Drugs Market Share by Players in 2022

Figure 18. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)

Figure 19. The Top 10 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2022

Figure 20. North America Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. North America Pediatric Orphan Drugs Market Share by Country (2018-2029)

Figure 22. United States Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Canada Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Pediatric Orphan Drugs Market Share by Country (2018-2029)

Figure 26. Germany Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. France Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. U.K. Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Italy Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Russia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Nordic Countries Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Asia-Pacific Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2018-2029)

Figure 34. China Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Japan Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. South Korea Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Southeast Asia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. India Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Australia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Latin America Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Latin America Pediatric Orphan Drugs Market Share by Country (2018-2029)

Figure 42. Mexico Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Brazil Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Middle East & Africa Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Middle East & Africa Pediatric Orphan Drugs Market Share by Country (2018-2029)

Figure 46. Turkey Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Saudi Arabia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Recordati SpA Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 49. Novartis Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 50. Celgene Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 51. Abbvie Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 52. Orpharma Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 53. Amgen Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 54. Amryt Pharma Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 55. Johnson & Johnson Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 56. GSK Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 58. Roche Holding Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 59. Pfizer Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 60. Sanofi Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 61. Takeda Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Addison's Disease Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15W2944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cryochambers Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37W6047

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Drug Repurposing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23J5563

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Consumer mHealth Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11I6310

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions